VeriSIM Life Company
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational-based solutions, customized for the pre-clinical and clinical programs. These offerings are all centered around their proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses.
Investors
.jpeg)
.png)
.png)
.png)
.png)
(Reupload).png)
.jpeg)
.png)
.png)
.jpeg)
Technology:
Artificial Intelligence, Health Care, Machine Learning, SaaS
Industry:
Preclinical Development
Headquarters:
San Francisco, California, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
15
Total Funding:
21655908
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-01-13
Last Funding Type:
Series A
Register and Claim Ownership